Morgan Stanley Downgrades Ambev S.A. (ABEV) to Equalweight
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Morgan Stanley downgraded Ambev S.A. (NYSE: ABEV) from Overweight to Equalweight with a price target of $6.40 (from $6.00).
Shares of Ambev S.A. closed at $6.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Cowen Downgrades Under Armour, Inc. (UA) to Market Perform
- Credit Suisse Downgrades Chipotle Mexican Grill (CMG) to Neutral; 'New Normal'
- Leerink Partners Cuts Price Target on Cynosure (CYNO) Following Solid 3Q
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Related EntitiesMorgan Stanley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!